Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combinatorial Gene Control02:33

Combinatorial Gene Control

9.7K
Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
9.7K
Group Design02:01

Group Design

10.8K
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
10.8K
Therapeutic Index01:13

Therapeutic Index

7.0K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
7.0K
Factorial Design02:01

Factorial Design

14.2K
Factorial Analysis is an experimental design that applies Analysis of Variance (ANOVA) statistical procedures to examine a change in a dependent variable due to more than one independent variable, also known as factors. Changes in worker productivity can be reasoned, for example, to be influenced by salary and other conditions, such as skill level. One way to test this hypothesis is by categorizing salary into three levels (low, moderate, and high) and skills sets into two levels (entry level...
14.2K
Design Example: Designing a Residential Plumbing System01:25

Design Example: Designing a Residential Plumbing System

1.2K
The design of residential plumbing systems requires carefully evaluating water demand, flow rates, and pressure dynamics to ensure both efficiency and reliability. The nature of water flow within pipes is defined by its Reynolds number, which classifies flow as either laminar (smooth) or turbulent.
1.2K
Sinusoidal Sources01:18

Sinusoidal Sources

1.2K
Direct current (DC) refers to an electric current that flows in a single direction, maintaining a constant polarity. This is in contrast to alternating current (AC), which periodically changes its direction and magnitude. AC forms the backbone of modern electricity transmission and distribution systems due to its efficient long-distance transmission capabilities.
In homes, the power supplies use sinusoidal sources to provide electricity. These sources generate a voltage that varies sinusoidally...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CT Perfusion Blood Flow Provides an Early Response Marker for Progression-free Survival in a Prospective Randomized Clinical Trial of Metastatic Renal Cell Carcinoma.

Technology in cancer research & treatment·2026
Same author

Special issue: cell and gene causal inference in the design and analysis of gene therapy clinical trials.

Journal of biopharmaceutical statistics·2026
Same author

Pretreatment Risk Model for Radiation-Induced Lymphopenia Is Associated With Adjuvant Durvalumab Efficacy in Patients With Unresectable Stage III NSCLC.

International journal of radiation oncology, biology, physics·2026
Same author

PD-L1 subpopulations of metastatic urothelial carcinoma demonstrate heterogeneity to chemotherapy: an integrated analysis of digitized trial results.

Cancer metastasis reviews·2026
Same author

Preoperative Weight Trends in Adolescents Undergoing Metabolic and Bariatric Surgery.

Obesity (Silver Spring, Md.)·2026
Same author

Jointly modeling multiple endpoints for efficient treatment effect estimation in randomized controlled trials.

Biometrics·2026
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
Same journal

Finite mixtures of linear quantile regressions with concomitant variables: a solution to endogeneity in longitudinal data modeling.

Biometrics·2026
Same journal

Discussion on "INTACT: a method for integration of longitudinal physical activity data from multiple sources" by Jingru Zhang, Erjia Cui, Hongzhe Li, and Haochang Shou.

Biometrics·2026
See all related articles

Related Experiment Video

Updated: Feb 15, 2026

Development of Combinatorial Therapeutics for Spinal Cord Injury using Stem Cell Delivery
05:13

Development of Combinatorial Therapeutics for Spinal Cord Injury using Stem Cell Delivery

Published on: June 7, 2024

527

A multi-source adaptive platform design for testing sequential combinatorial therapeutic strategies.

Alexander M Kaizer1, Brian P Hobbs2, Joseph S Koopmeiners1

  • 1Division of Biostatistics, University of Minnesota, Minneapolis, Minnesota, U.S.A.

Biometrics
|January 24, 2018
PubMed
Summary
This summary is machine-generated.

This study introduces an adaptive platform trial design to improve statistical power in clinical research. The new method enhances power by up to 51% compared to traditional designs, optimizing therapeutic strategy comparisons.

Keywords:
Adaptive randomizationEbola virus diseaseEmerging infectious diseasesMulti-source smoothingPlatform design

More Related Videos

Computerized Adaptive Testing System of Functional Assessment of Stroke
05:21

Computerized Adaptive Testing System of Functional Assessment of Stroke

Published on: January 7, 2019

6.3K
Using Practice Testing, Public Speaking, and Source Monitoring to Examine the Influences of Learning Strategies and Stress on Episodic Memory
07:59

Using Practice Testing, Public Speaking, and Source Monitoring to Examine the Influences of Learning Strategies and Stress on Episodic Memory

Published on: June 14, 2019

8.4K

Related Experiment Videos

Last Updated: Feb 15, 2026

Development of Combinatorial Therapeutics for Spinal Cord Injury using Stem Cell Delivery
05:13

Development of Combinatorial Therapeutics for Spinal Cord Injury using Stem Cell Delivery

Published on: June 7, 2024

527
Computerized Adaptive Testing System of Functional Assessment of Stroke
05:21

Computerized Adaptive Testing System of Functional Assessment of Stroke

Published on: January 7, 2019

6.3K
Using Practice Testing, Public Speaking, and Source Monitoring to Examine the Influences of Learning Strategies and Stress on Episodic Memory
07:59

Using Practice Testing, Public Speaking, and Source Monitoring to Examine the Influences of Learning Strategies and Stress on Episodic Memory

Published on: June 14, 2019

8.4K

Area of Science:

  • Clinical trial methodology
  • Statistical modeling in medicine
  • Infectious disease research

Background:

  • Traditional clinical trial designs face challenges with multiple concurrent therapeutic strategies.
  • Platform trials, like PREVAIL II for Ebola, sequentially compare therapies under a single protocol.
  • PREVAIL II's design limited data leverage to avoid bias, potentially reducing statistical power.

Purpose of the Study:

  • To describe an adaptive platform trial design using Bayesian modeling and adaptive randomization.
  • To enhance statistical power and information balance in sequential therapeutic comparisons.
  • To address limitations of previous platform trial designs, such as PREVAIL II.

Main Methods:

  • Utilized Bayesian multi-source exchangeability models to integrate data across trial segments.
  • Implemented adaptive randomization for improved information balance within segments.
  • Compared the proposed adaptive design against the PREVAIL II design.

Main Results:

  • The adaptive platform design demonstrated a power increase of up to 51% compared to the PREVAIL II design.
  • The proposed method showed limited type-I error inflation.
  • Achieved better balance in information distribution among study arms, with increased randomization to experimental treatments.

Conclusions:

  • Adaptive platform trial designs offer significant improvements in statistical power and efficiency.
  • Bayesian modeling and adaptive randomization are effective strategies for optimizing clinical trial designs.
  • This methodology can enhance the evaluation of multiple therapeutic strategies in clinical research.